In line with our findings, PAFAH1B2 was no significantly upregulated in human breast tumors, but targeting PAFAH1B2 could also significantly impaired proliferation, survival, migration, and invasiveness in breast cancer cells (34). This evidence concerns the gene PAFAH1B2 and breast cancer.